A landmark independent study validates ENvue’s platform with improved outcomes, reduced imaging, nursing time savings, and lower costs. Clinical proof + economic value = adoption potential. $FEED @ENvueMedical https://t.co/CMoyO6knox
Seven years into our journey and excited to join a curated group of public companies at the Sohn Emerging Company Pavilion. Grateful for the chance to connect with investors supporting both innovation and the fight against pediatric cancer.
🗣️ "A lot of it is TBD ... The other news that came out with the rescheduling ... the DOJ put in a recommendation to the treasury to give us back our back taxes."
- @JasonGWild Chairman of @terrascendcorp $TSNDF
🎦 WATCH: https://t.co/mLAb42NqgA
🌿 ETFs: 🌎 $YOLO 🇺🇸 $MSOS
“Capital likes clarity.” @AnthonyConigli0 joins @TheDalesReport to discuss the April 23 shift to Schedule III—moving cannabis from regulatory uncertainty toward fundamentals like cash flow, balance sheets, and scalable growth as institutional capital looks to re-engage. https://t.co/kERMSWoQyv $NLCP
@newcelXltd $NCEL Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with @Eledon_Pharma $ELDN in 2026 - https://t.co/QLRK3VYdwK
BTCS CEO Charles Allen recently spoke on the Webull Digital Asset Treasury Crypto Webinar about our differentiated strategy and the opportunity we see as an Ethereum-focused company.
Watch the webinar here: https://t.co/5epzqCb6Lu
What I’m watching this week: Fed likely to hold rates steady; in Virginia, the governor is poised to sign adult‑use sales legislation, setting up the next East Coast rec market; watching a wave of “medical cannabis in hospitals” bills in VA/WA/DE (with CT/HI in the mix) as states quietly normalize end‑of‑life use in healthcare settings.
$NXGL Signs Definitive Agreement to License Transformative Portfolio of Regenerative Biomaterial Products $CELU; expected to triple annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing - https://t.co/j3om5fCfw2
Congrats to @niagenbio $NAGE Reporting 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025 - https://t.co/iPZvOgNSpz
Tomorrow, BTCS will host Part 1 of our new AMA Webinar Series at 2:30 PM ET. Tune in to hear me discuss our capital strategy and how BTCS strategically raises and deploys our assets across the Ethereum ecosystem.
Register Here: https://t.co/8Q8eK96EMy
$MCRP Signs $9.3 Million Commercial Development and Multi-Year Distribution Agreement with AfricAI to Expand AI-Driven Autonomous Vehicles Across Africa - https://t.co/iXEbQFieep